Sulfadiazine: Difference between revisions
From IDWiki
(Created page with "* Antimicrobial that inhibits dihydrofolic acid synthesis * Indications include Is treatment for::toxoplasmosis, Is treatment for::malaria, and Is treatment for::Noc...") |
No edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 2: | Line 2: | ||
* Indications include [[Is treatment for::toxoplasmosis]], [[Is treatment for::malaria]], and [[Is treatment for::Nocardia]] |
* Indications include [[Is treatment for::toxoplasmosis]], [[Is treatment for::malaria]], and [[Is treatment for::Nocardia]] |
||
* Adverse events include |
* Adverse events include |
||
** GI intolerance |
** [[Adverse drug reaction::GI intolerance]] |
||
** Pruritic rash |
** [[Adverse drug reaction::Pruritic rash]] |
||
** Bone marrow suppression of any line |
** [[Adverse drug reaction::Bone marrow suppression]] of any line |
||
** Serum sickness and drug fever |
** [[Adverse drug reaction::Serum sickness]] and [[Adverse drug reaction::drug fever]] |
||
** Crystal-induced nephropathy |
** [[Adverse drug reaction::Crystal-induced nephropathy]] |
||
** Photosensitivity |
** [[Adverse drug reaction::Photosensitivity]] |
||
** Hepatitis |
** [[Adverse drug reaction::Hepatitis]] |
||
[[Category:Antibiotics]] |
|||
Latest revision as of 03:19, 18 February 2020
- Antimicrobial that inhibits dihydrofolic acid synthesis
- Indications include toxoplasmosis, malaria, and Nocardia
- Adverse events include
